Document is current
Any future updates will be listed below
-
Authors
Whelchel, Kristen https://orcid.org/0000-0003-3393-7863
Zuckerman, Autumn D. https://orcid.org/0000-0002-8376-0691
DeClercq, Josh https://orcid.org/0000-0002-8171-5766
Choi, Leena https://orcid.org/0000-0002-2544-7090
Kelly, Sean G. https://orcid.org/0000-0002-4383-5951
- License Information
-
More Information
Article History
Accepted: 15 May 2023
First Online: 2 June 2023
Declarations
:
: Dr. Kelly has served on advisory boards for Gilead Sciences, ViiV, and Theratechnologies. Dr. Zuckerman receives research support from AstraZeneca, Pfizer, BeiGene, and Sanofi. The other authors declare no relevant conflicts of interest or financial relationships.
: This research study was conducted retrospectively from data obtained for clinical purposes. This study was approved by the institutional review board of Vanderbilt University as an exempt study and a waiver of consent was granted.
: Not applicable.
: Not applicable.
